Instructors
Michael Tucker
, Medidata, a Dassault Systèmes Company, United States
Michael is a member of Medidata’s Mobile Health team and is a subject matter expert in electronic informed consent and virtual trials. Over the last six years, Michael has worked collaboratively with sponsors, CROs, regulators, ethics committees and researchers around the world to pioneer the use of electronic informed consent and virtual trials. His 30-year career in medical research includes 8 years with the US government conducting and supporting surgical research and 22 years working in the commercial sector. Michael has been a participant in two clinical trials...but had to consent on paper because eConsent had not been invented yet!
Brian Barnes, MA
Director, Risk Management Strategy, Global Clinical Development Operations, BioNTech, United States
Brian has 17 years in clinical development and has specifically supported RBQM for ten years specializing in operational solutions for small to large pharma, biopharma, and biotech companies. Brian is a co-liaison within the Association of Clinical Research Organizations (ACRO) RBQM Working Group and presented and published on RBQM at industry meetings, conferences, and journals. Brian received his Bachelor of Science in Kinesiology from San Diego State University and Master of Art in Human Physiology from the University of Texas at Austin.
Holly Robertson, PhD, PMP
Senior Director, Advisory & Enablement Services, Medidata, a Dassault Systèmes company, United States
Holly Robertson is the Sr. Director of Advisory & Enablement Services within the Patient Cloud team at Medidata Solutions, with over 20 years of experience in pre-clinical and clinical research. Dr. Robertson obtained her PhD in Pharmacology from the University of Colorado Health Sciences Center and conducted pre-clinical and translational research at both Duke University and the McGovern Institute for Brain Research at MIT. Prior to joining Medidata, Dr. Robertson was at Duke Clinical Research Institute where she led her team in developing operational strategies for decentralized clinical trials (DCTs). Most notably she was the project lead for the ADAPTABLE Study, a fully virtual study with over 15,000 patients enrolled.
Aryana Hosseinkhani
Senior Director Product Marketing, Patient Cloud, Medidata, a Dassault Systèmes company, United States
Aryana Hosseinkhani is the Senior Director of Product Marketing in Patient Cloud at Medidata, a Dassault Systemes Company. She completed her education at the University of California, Davis in Genetics and shortly after began working as a bench scientist in stem cell research. Aryana began her clinical research career at Science 37 around 8 years ago, as the third employee and a founding partner. At Medidata, she focuses on product and patient communications in patient-facing technologies. She is passionate about the value of research and seeing it through from the bench to the real world. Over her career, she has focused on disruptive and innovative technologies that can simplify clinical trials for patients, sites, and sponsors.